Study guide

5.4 Caffeine, Theophylline, and Over-the-Counter Stimulants

Certified Specialist in Poison Information CSPI

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pharmacology & Toxicology Principles

1.1 Toxicokinetics: Absorption, Distribution, Metabolism, and Elimination Alterations in Overdose 1.2 Toxicodynamics, Receptor Pharmacology, and Dose-Response Relationships 1.3 Cellular and Biochemical Mechanisms of Toxicity 1.4 Hepatic Biotransformation, Phase I/II Reactions, and CYP450 Interactions

2 Chapter 2: Poison Center Case Assessment Fundamentals

2.1 Exposure History: The Questions That Change Management 2.2 Toxicologic Calculations: Doses, Concentrations, and Conversions

3 Chapter 3: Analgesics, Opioids & Over-the-Counter Medications

3.1 Acetaminophen Overdose: Pathophysiology, Rumack-Matthew Nomogram, and NAC Protocols 3.2 Salicylates: Pathophysiology, Acid-Base Derangements, and Urinary Alkalinization 3.3 Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Miscellaneous OTC Analgesics 3.4 Opioids, Opioid Toxidrome, and Naloxone Titration 3.5 Cough and Cold Products, Antihistamines, Muscle Relaxants, and Local Anesthetics

4 Chapter 4: Psychotropic & Neurologic Medications

4.1 Tricyclic and Cyclic Antidepressants: Cardiotoxicity, ECG Findings, and Bicarbonate Therapy 4.2 SSRIs, SNRIs, Novel Antidepressants, and Serotonin Syndrome 4.3 Antipsychotics, Neuroleptic Malignant Syndrome, and Lithium Neurotoxicity 4.4 Benzodiazepines, Z-drugs, Barbiturates, and Major Anticonvulsants

5 Chapter 5: Cardiovascular Drugs & Substances of Abuse

5.1 Beta-Blockers, Calcium Channel Blockers, and High-Dose Insulin Euglycemia Therapy 5.2 Digoxin and Cardiac Glycosides: Mechanism, Arrhythmias, and Digoxin Immune Fab 5.3 Sympathomimetics, Cocaine, Amphetamines, Synthetic Cannabinoids, and Hallucinogens 5.4 Caffeine, Theophylline, and Over-the-Counter Stimulants 5.5 Cannabis, GHB, Nitrites, and Nicotine Products

6 Chapter 6: Endocrine, Antimicrobial & Miscellaneous Medications

6.1 Antidiabetic Agents, Metformin Lactic Acidosis, and Thyroid Hormone 6.2 Antimicrobials, Vitamins and Minerals, and Veterinary Products

7 Chapter 7: Household, Chemical & Inhalational Toxins

7.1 Caustic and Corrosive Ingestions: Acids vs. Alkalis, Tissue Necrosis, and Endoscopic Grading 7.2 Cleaning Products, Personal Care Products, and Household Chemicals 7.3 Hydrocarbons and Halogenated Solvents: Aspiration Risks and Myocardial Sensitization 7.4 Carbon Monoxide, Cyanide, Hydrogen Sulfide, and Inhalational Irritants

8 Chapter 8: Pesticides, Heavy Metals & Toxic Alcohols

8.1 Organophosphates, Carbamates, Pyrethroids, and Cholinesterase Antidotes 8.2 Rodenticides, Herbicides, Repellents, and Other Pesticides 8.3 Ethylene Glycol, Methanol, and Isopropanol: Metabolism, Osmolal Gaps, and Fomepizole 8.4 Lead, Mercury, Arsenic, Iron Toxicity, and Chelation Protocols

9 Chapter 9: Toxic Plants, Mushrooms & Foodborne Toxins

9.1 Toxic Plants: Cardiac Glycosides, Anticholinergics, Nicotinics, and Sodium Channel Activators 9.2 Oxalate, Irritant, Hallucinogenic, and Stimulant Plants 9.3 Mushroom Poisoning: Amatoxins, Monomethylhydrazine, Muscarine, and Coprine 9.4 Scombroid, Ciguatera, Tetrodotoxin, Paralytic Shellfish, and Botulism 9.5 Bacterial Foodborne Illness and Food Poisoning Triage

10 Chapter 10: Envenomations & Bites

10.1 North American Pit Vipers (Crotalinae): Envenomation Assessment and Antivenom Management 10.2 Elapid Snakebites (Coral Snakes): Neurotoxicity, Clinical Course, and Antivenin 10.3 Black Widow, Brown Recluse Spiders, and Bark Scorpion Stings 10.4 Hymenoptera Stings, Ticks, and Other Arthropods 10.5 Marine Envenomations: Jellyfish, Stingrays, Catfish, and Lionfish

11 Chapter 11: Clinical Assessment, Toxidromes & Triage

11.1 Recognition of Classic Toxidromes and Vital Sign Pattern Analysis 11.2 Severity Assessment, Exposure Urgency, and Poison Center Telephone Triage Flow 11.3 Home Observation vs. Emergency Department Referral Decision-Making 11.4 Diagnostic Toxicology: Acid-Base Analysis, Gaps, ECG Intervals, and Drug Testing

12 Chapter 12: Decontamination, Antidotes & Elimination

12.1 Gastrointestinal Decontamination: Activated Charcoal, Whole Bowel Irrigation, and Contraindications 12.2 Essential Poison Center Antidotes: Indications, Mechanisms, and Titration Pearls 12.3 Enhanced Elimination: Urinary Alkalinization, MDAC, Hemodialysis, and Hemoperfusion 12.4 Resuscitation and Supportive Care: Seizures, Hyperthermia, and Hemodynamic Shock

13 Chapter 13: Pediatric Poisoning & High-Risk Hazards

13.1 Pediatric "One-Pill-Can-Kill" Agents and Pediatric Toxic Dose Thresholds 13.2 Button Batteries, Rare-Earth Magnets, and Expandable Foreign Bodies 13.3 Developmental Ingestion Patterns, Liquid Detergent Pods, and Essential Oils

14 Chapter 14: Communication, NPDS Documentation & Prevention

14.1 Emergency Call Communication, Panicked Callers, and Healthcare Provider Consultations 14.2 National Poison Data System (NPDS) Coding Standards and Medical Outcome Categorization 14.3 Scheduled Follow-up Protocols, Medical Toxicologist Consultation Triggers, and Public Health Surveillance 14.4 Evidence-Based Poison Prevention, PPPA Regulations, and Community Outreach

5.4 Caffeine, Theophylline, and Over-the-Counter Stimulants

Key Takeaways Explain This Topic AI

Methylxanthines antagonize adenosine receptors and inhibit phosphodiesterase, producing catecholamine excess with tachydysrhythmias, tremor, vomiting, seizures, and a metabolic triad of hypokalemia, hyperglycemia, and metabolic acidosis.

Hypokalemia in theophylline or caffeine toxicity reflects an intracellular shift rather than total body loss, so potassium is replaced cautiously to avoid rebound hyperkalemia.

Theophylline seizures are often refractory and can occur without preceding tachycardia; multiple-dose activated charcoal shortens the half-life substantially, and EXTRIP recommends extracorporeal treatment for acute levels above 100 mg/L or for seizures, life-threatening dysrhythmias, or shock.

Caffeine powders and concentrated energy products have caused deaths in young adults, with roughly 150 to 200 mg/kg considered potentially lethal, and a single teaspoon of pure powder containing several grams.

Sympathomimetic decongestants and weight-loss supplements cause hypertension with reflex bradycardia (phenylephrine), stroke and dysrhythmias (ephedra-type alkaloids), and severe hyperthermia with 2,4-dinitrophenol, for which there is no antidote.

Last updated: September 2026

Methylxanthine Pharmacology

Caffeine, theophylline, and aminophylline (a theophylline-ethylenediamine salt) act through three linked mechanisms:

Adenosine receptor antagonism , removing adenosine's inhibitory brake on central neurons, the sinoatrial node, and presynaptic catecholamine release. This is the main reason seizures and tachydysrhythmias occur.

Phosphodiesterase inhibition , raising intracellular cyclic adenosine monophosphate and amplifying beta-adrenergic signaling.

Increased catecholamine release , producing beta-1 and beta-2 effects clinically indistinguishable from an epinephrine infusion.

The Clinical and Metabolic Signature

System Findings

Cardiovascular Sinus tachycardia, supraventricular tachycardia, atrial fibrillation, ventricular ectopy and ventricular tachycardia; beta-2 mediated vasodilation causes a wide pulse pressure and hypotension despite tachycardia

Neurologic Anxiety, tremor, hyperreflexia, agitation, then seizures that are frequently refractory and may be the first manifestation in chronic toxicity

Gastrointestinal Intractable vomiting (a major barrier to oral charcoal), abdominal pain, hematemesis

Metabolic Hypokalemia (beta-2 driven intracellular shift), hyperglycemia , hypophosphatemia , hypomagnesemia , lactic acidosis, and leukocytosis

Potassium pearl: the hypokalemia is a shift, not a deficit. Aggressive replacement produces rebound hyperkalemia as the drug is cleared. Replace enough to prevent dysrhythmia (generally keeping potassium above about 3.0 mEq/L) and recheck frequently.

Acute Versus Chronic Theophylline Toxicity

  • Feature Acute Overdose Chronic Accumulation
  • Typical patient Intentional ingestion Older adult with an illness, heart failure, or a new interacting drug
  • Level at which seizures occur Usually above 80 to 100 mg/L Often 40 to 60 mg/L
  • Vomiting and hypokalemia Prominent Less prominent
  • Prognosis for a given level Better Worse

Common precipitants of chronic toxicity are drugs that inhibit CYP1A2 (ciprofloxacin, fluvoxamine, cimetidine, erythromycin), viral illness, and heart failure. Smoking cessation also raises levels because tobacco smoke induces CYP1A2.

Management of Methylxanthine Toxicity

Decontamination: activated charcoal early; multiple-dose activated charcoal is one of the few evidence-supported indications and can shorten the elimination half-life by more than half. Aggressive antiemetics (ondansetron, often in high doses; metoclopramide) are needed to keep charcoal down.

Seizures: benzodiazepines first, then phenobarbital or propofol. Phenytoin is ineffective.

Dysrhythmias and hypotension: a short-acting beta-blocker (esmolol infusion, or small doses of propranolol) treats the beta-mediated tachycardia and vasodilation; this is the rare situation where beta-blockade in a hyperadrenergic patient is correct. Fluid resuscitation supports the vasodilated circulation.

Electrolytes: cautious potassium, magnesium, and phosphate repletion.

Extracorporeal treatment (EXTRIP): recommended for an acute theophylline level above 100 mg/L , or for seizures, life-threatening dysrhythmias, shock, a rising level despite optimal care, or clinical deterioration. It is suggested for chronic levels above 60 mg/L , for chronic levels above 50 mg/L in patients younger than 6 months or older than 60 years, and when gastrointestinal decontamination cannot be given. Intermittent hemodialysis is preferred, and multiple-dose charcoal continues during dialysis.

Caffeine in Modern Products

  • Source Typical Caffeine Content
  • Brewed coffee, 8 oz 95 to 165 mg
  • Energy drink, 16 oz 150 to 300 mg
  • Energy "shot," 2 oz 200 to 250 mg
  • Caffeine tablet 100 to 200 mg
  • Pure caffeine powder, 1 teaspoon About 3,000 to 5,000 mg

Toxicity begins around 10 to 15 mg/kg , serious toxicity above roughly 50 mg/kg , and death has occurred near 150 to 200 mg/kg .

Deaths in healthy young adults have followed the use of bulk caffeine powder measured with a kitchen spoon, which is why the specialist asks specifically whether a powder or concentrated liquid was used rather than tablets.

Neonates are an exception: caffeine citrate is therapeutic for apnea of prematurity, and neonates tolerate levels that would be toxic in adults.

Sympathomimetic Decongestants and Diet Products

Agent Mechanism Overdose Features Notes

Pseudoephedrine Mixed direct and indirect sympathomimetic Hypertension, tachycardia, agitation, mydriasis; seizures in large ingestions Common in pediatric exploratory ingestions

Phenylephrine Selective alpha-1 agonist Hypertension with reflex bradycardia , headache, pallor The bradycardia is baroreflex-mediated, not a second toxin

Ephedrine and pseudoephedrine-containing botanicals (ephedra, ma huang) Indirect release of norepinephrine Hypertensive crisis, stroke, myocardial infarction, dysrhythmias Removed from US dietary supplements in 2004 but still found in imported products

Bitter orange (synephrine) and caffeine blends Adrenergic stimulation Palpitations, hypertension, chest pain Frequently sold as "ephedra-free"

Yohimbine Central alpha-2 antagonist Anxiety, hypertension, tachycardia, diaphoresis, priapism Opposite of clonidine

Thyroid hormone in "metabolism" products Adds adrenergic effects Delayed tachycardia and tremor Covered with endocrine medications

2,4-Dinitrophenol (DNP) Uncouples oxidative phosphorylation Profuse sweating, tachypnea, extreme hyperthermia above 42 °C , rigor, death; yellow skin staining Illegal but sold online for fat loss; no antidote , aggressive cooling and sedation only

Management of Stimulant Ingestions

Benzodiazepines are the cornerstone for agitation, hypertension, tachycardia, and hyperthermia.

Active cooling for temperatures above 40 °C; antipyretics do not work.

For sustained severe hypertension, use a titratable vasodilator (nicardipine, nitroglycerin) or phentolamine rather than a pure beta-blocker in cocaine-type exposures. Methylxanthines are the exception where beta-blockade is indicated.

Check glucose, potassium, creatine kinase, and an ECG; look for QT prolongation and ischemia.

Poison Center Case: Bulk Caffeine Powder

A 22-year-old bodybuilder is brought in after mixing "a couple of scoops" of bulk caffeine powder into a pre-workout drink. He is vomiting repeatedly, tremulous, and anxious. Heart rate is 165 with a narrow-complex rhythm, blood pressure is 88/40, potassium is 2.6 mEq/L, glucose is 265 mg/dL, and lactate is 6 mmol/L.

Specialist actions. The CSPI recognizes the classic methylxanthine picture: hyperadrenergic tachycardia with beta-2 mediated hypotension plus hypokalemia, hyperglycemia, and lactic acidosis. Recommendations are ondansetron to control vomiting so that multiple-dose activated charcoal can be given, intravenous fluids, cautious potassium and magnesium replacement with frequent rechecks because the hypokalemia is a shift, an esmolol infusion for the tachydysrhythmia and vasodilatory hypotension, benzodiazepines at the bedside for seizure precautions, and a caffeine level with nephrology notified because severe caffeine toxicity, like theophylline, responds to hemodialysis.